Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-15

FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approval of a generic neostigmine methylsulfate product (ANDA) by Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine Methylsulfate (neostigmine methylsulfate)

Snippet

ORIG AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)